(Q61902304)
Statements
SNAP101 (English)
0 references
Phase1 Randomized, Double-Blind, Placebo/Active-Controlled, SAD, 2-Way, Incomplete Block, 2-Period Crossover, Safety, Tolerability, PK/PD Study of 3 Doses INP105 (Olanzapine Delivered by I231 POD® Device) Nasal Spray in Healthy Volunteers (English)
0 references
5 August 2018
0 references
3 October 2018
0 references
38
0 references
18 year
0 references
55 year
0 references